Similarly, promoter hypermethylation of ATG4D, ATG2B, ATG9A, and ATG9B genes has been demonstrated in most invasive ductal carcinomas (IDC), and this enhanced methylation was associated with the cancer grade, reduced gene expression, and lymph node metastasis [24]. The gene discussed is ATG9B; the disease is cancer.